• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.26% Nasdaq Down0.34%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    3.28 Up 0.05(1.55%) Jul 6, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 5,734   7,956   3,754  
    Cost of Revenue -   -   -  
    Gross Profit 5,734   7,956   3,754  
    Operating Expenses
    Research Development27,665  28,891  29,185  
    Selling General and Administrative23,112  10,838  9,175  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (45,043) (31,773) (34,606)
    Income from Continuing Operations
    Total Other Income/Expenses Net3,760  92  (7,490)
    Earnings Before Interest And Taxes(41,283)(31,681)(42,096)
    Interest Expense1,719  2,917  1,855  
    Income Before Tax(43,002)(34,598)(43,951)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(43,002)(34,598)(43,951)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (43,002) (34,598) (43,951)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (43,002) (34,598) (43,951)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.